This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2001 Dec;5(12):1078-9.

Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?

R Gupta¹, M C Raviglione, M A Espinal

Affiliations

PMID: 11769764

Review

Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?

R Gupta et al. Int J Tuberc Lung Dis. 2001 Dec.

. 2001 Dec;5(12):1078-9.

Authors

R Gupta¹, M C Raviglione, M A Espinal

Affiliation

¹ World Health Organization.

PMID: 11769764

No abstract available

PubMed Disclaimer

Comment in

Rebuttal, evidence and debate.
Harper I. Harper I. Int J Tuberc Lung Dis. 2003 Jan;7(1):100. Int J Tuberc Lung Dis. 2003. PMID: 12701844 No abstract available.

Similar articles

Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK, Kim JH, Kang H, Cho JS, Smego RA Jr. Park SK, et al. Int J Infect Dis. 2009 Mar;13(2):170-5. doi: 10.1016/j.ijid.2008.06.001. Epub 2008 Sep 2. Int J Infect Dis. 2009. PMID: 18768342
Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
Pablos-Mendez A, Gowda DK, Frieden TR. Pablos-Mendez A, et al. Bull World Health Organ. 2002;80(6):489-95; discussion 495-500. Bull World Health Organ. 2002. PMID: 12132008 Free PMC article.
Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?
Coker R. Coker R. Int J Tuberc Lung Dis. 2002 Aug;6(8):649-50. Int J Tuberc Lung Dis. 2002. PMID: 12150473 No abstract available.
A case series: initial outcome of persons with multidrug-resistant tuberculosis after treatment with the WHO standard retreatment regimen in Ho Chi Minh City, Vietnam.
Lan NTN, Lademarco MF, Binkin NJ, Tung LB, Quy HT, Cĵ NV. Lan NTN, et al. Int J Tuberc Lung Dis. 2001 Jun;5(6):575-8. Int J Tuberc Lung Dis. 2001. PMID: 11409587 Review.
Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment.
Ormerod LP. Ormerod LP. Br Med Bull. 2005 Jun 14;73-74:17-24. doi: 10.1093/bmb/ldh047. Print 2005. Br Med Bull. 2005. PMID: 15956357 Review.

See all similar articles

Cited by

Implementation validation performed in Rwanda to determine whether the INNO-LiPA Rif.TB line probe assay can be used for detection of multidrug-resistant Mycobacterium tuberculosis in low-resource countries.
Quezada CM, Kamanzi E, Mukamutara J, De Rijk P, Rigouts L, Portaels F, Ben Amor Y. Quezada CM, et al. J Clin Microbiol. 2007 Sep;45(9):3111-4. doi: 10.1128/JCM.00590-07. Epub 2007 Jul 11. J Clin Microbiol. 2007. PMID: 17626172 Free PMC article.
Mutation detection and accurate diagnosis of extensively drug-resistant tuberculosis: report from a tertiary care center in India.
Ajbani K, Rodrigues C, Shenai S, Mehta A. Ajbani K, et al. J Clin Microbiol. 2011 Apr;49(4):1588-90. doi: 10.1128/JCM.00113-11. Epub 2011 Feb 2. J Clin Microbiol. 2011. PMID: 21289142 Free PMC article.
Rapid detection of ofloxacin resistance in Mycobacterium tuberculosis by two low-cost colorimetric methods: resazurin and nitrate reductase assays.
Martin A, Palomino JC, Portaels F. Martin A, et al. J Clin Microbiol. 2005 Apr;43(4):1612-6. doi: 10.1128/JCM.43.4.1612-1616.2005. J Clin Microbiol. 2005. PMID: 15814974 Free PMC article.
Cost-effectiveness of treating multidrug-resistant tuberculosis.
Resch SC, Salomon JA, Murray M, Weinstein MC. Resch SC, et al. PLoS Med. 2006 Jul;3(7):e241. doi: 10.1371/journal.pmed.0030241. PLoS Med. 2006. PMID: 16796403 Free PMC article.
To control and beyond: moving towards eliminating the global tuberculosis threat.
Brewer TF, Heymann SJ. Brewer TF, et al. J Epidemiol Community Health. 2004 Oct;58(10):822-5. doi: 10.1136/jech.2003.008664. J Epidemiol Community Health. 2004. PMID: 15365106 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ingenta plc